Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TASE:PTBL
TASE:PTBLReal Estate

A Look At Property & Building (TASE:PTBL) Valuation After US Court Clears Summit Apartment Deal Bidding

A US bankruptcy court has allowed the bidding process to continue for over 5,000 Brooklyn apartments tied to Summit Properties, an affiliate of Property & Building (TASE:PTBL), keeping this large US real estate transaction in play for investors. See our latest analysis for Property & Building. The court decision comes as Property & Building’s share price trades at ₪428.4, with an 11.85% 1 month share price return and an 8.46% year to date share price return. The 1 year total shareholder...
LSE:RPI
LSE:RPITech

3 UK Stocks That May Be Undervalued In January 2026

The UK stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices both closing lower amid concerns over weak trade data from China, highlighting the interconnectedness of global economies. In such an environment, identifying undervalued stocks can be crucial for investors seeking opportunities that may offer potential value despite broader market uncertainties.
AIM:TRB
AIM:TRBConsumer Services

Spotlight On 3 UK Penny Stocks With Market Caps Under £200M

The United Kingdom's stock market has recently faced downward pressure, with the FTSE 100 and FTSE 250 indices both closing lower amid concerns over weak trade data from China. Despite these broader market challenges, certain investment opportunities continue to hold promise for those willing to explore beyond the blue-chip stocks. Penny stocks, though often viewed as a term from a bygone era, still represent viable prospects for growth when backed by strong financials and sound fundamentals.
NasdaqGS:RIGL
NasdaqGS:RIGLBiotechs

Rigel Pharmaceuticals (RIGL) Is Down 7.7% After Issuing Detailed 2026 Revenue Mix Guidance – Has The Bull Case Changed?

In January 2026, Rigel Pharmaceuticals issued full-year 2026 earnings guidance, projecting total revenue of about US$275 million to US$290 million, including US$255 million to US$265 million in net product sales and US$20 million to US$25 million in contract revenue. This fresh guidance gives investors a clearer view of how management currently sees the balance between core product sales and partnership-driven contract income. We’ll now consider how Rigel’s new 2026 revenue guidance,...
OB:KOA
OB:KOAAuto Components

European Penny Stocks With Market Caps Below €200M To Consider

As European markets continue to show optimism with major stock indexes rising, investors are increasingly looking towards smaller companies for potential opportunities. Penny stocks, a term that may seem outdated but still relevant, often refer to smaller or newer companies that can offer a blend of affordability and growth potential. By focusing on those with strong financials and clear growth prospects, investors might find these under-the-radar stocks appealing as they explore the...
BIT:YRM
BIT:YRMEnergy Services

Rosetti Marino And 3 Undiscovered Gems In Europe For Your Portfolio

As the European markets show signs of optimism with the STOXX Europe 600 Index climbing 2.27% amid positive economic indicators and a favorable interest rate environment, investors are increasingly looking towards small-cap stocks for potential opportunities. In this context, identifying undiscovered gems like Rosetti Marino can offer valuable diversification and growth potential in a portfolio, especially when these companies are positioned to benefit from current economic trends and...